SEO URLwww.firestrike.ai/deals/seamless-therapeutics-lilly-acquisition-2026-1
acquisitionAnnounced · Jan 28, 2026gene editingSource · CredibleArticle · Factual
Lilly acquires Seamless Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$1.1B
Target
Seamless Therapeutics
Acquirer
Lilly
Full Acquisition
Status
Announced
Lilly agreed to acquire Seamless Therapeutics. Reported deal value: $1.1B. Status: Announced. Sector: gene editing. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-28. Figures and status may change as filings and press coverage update.
Eli Lilly & Co. on Wednesday struck a $1.1 billion deal with Seamless Therapeutics for gene therapy solutions to treat hearing loss
Deal timeline
Announced
Jan 28, 2026 · newsable.asianetnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in gene editing with a reported deal value of $1.1B. Figures and status may change as sources update.
Sources: newsable.asianetnews.com · Primary article · FireStrike proprietary index